Autologous stem cell transplantation in multiple myeloma: a single center experience

This study shows the feasibility and safety of autologous stem cell transplantation in 32 of 98 multiple myeloma patients referred to our institution over a 3-year period. Complete response rate was 19% and partial response rate 58%. A significantly better outcome was shown among newly diagnosed patients in comparison with pretreated patients.